Researchers Find Correlation Between Pain and Overeating in Veterans
Over 40 percent of veterans screened by Yale researchers overate in response to physical pain at least once in the 30 days prior to being surveyed, a new study shows. The lead author of the study was Robin Masheb, PhD, Senior Research Scientist in Psychiatry at Yale School of Medicine.
Antidote to Pain and Negativity? Let It Be.
Hedy Kober, PhD, Associate Professor of Psychiatry and Psychology, is the corresponding author of a paper published in Social, Cognitive, and Affective Neuroscience that touts the benefits of mindfulness to help people deal with physical pain and negative emotions.
Trainee-Led Study Seeks to Better Understand All-Cause Mortality in Schizophrenia Patients
A new study led by a Yale Department of Psychiatry trainee sought to better understand why people with schizophrenia have dramatically increased all-cause mortality, and whether living with severe mental illness accelerates the aging process.
Wilkinson: What is the Deal with Esketamine?
Samuel Wilkinson, MD, Assistant Professor of Psychiatry and Assistant Director of the Yale Depression Research Program, writes in Psychiatric Times about the drug esketamine, approved by the U.S. Food and Drug Administration last year as the first rapid-acting therapy for treatment-resistant depression.
Yale Study: DNA Biomarkers Predict Hazardous Alcohol Consumption in Two Distinct Populations
Xiaoyu Liang, PhD, Postdoctoral Associate in the Yale Department of Psychiatry, and Ke Xu, MD, Associate Professor of Psychiatry, are the first and senior authors, respectively, of a study published in Molecular Psychiatry that found a set of DNA biomarkers that may predict hazardous alcohol drinking in two cohorts. The study may motivate future studies to replicate the findings and to establish genomic biomarkers for psychiatric disorders.
O'Dell, Mecca Awarded Travel Scholarships
Ryan O’Dell, MD, PhD, a third-year resident in the Yale Department of Psychiatry, and Adam Mecca, MD, PhD, Assistant Professor of Psychiatry, were both awarded the Human Amyloid Imaging 2020 Travel Scholarship for the organization’s annual conference in January 2020.
Substance Use Disorders in Later Life: A Review and Synthesis of the Literature of an Emerging Public Health Concern
Five current and former Yale Department of Psychiatry faculty and trainees contributed to a paper published in The American Journal of Geriatric Psychiatry that provides a clinical review and synthesis of existing literature around subsance use in later life.
Yale Review: Opioid Use in Pregnancy
Amalia Londono Tobon, MD, Clinical Fellow in the Yale Child Study Center; Erin Habecker, MD, a 2019 graduate of the Yale Psychiatry Residency Program; and Ariadna Forray, MD, Associate Professor of Psychiatry, are co-authors of a paper published in Current Psychiatry Reports that reviews recent evidence of perinatal outcomes and treatment of opioid use disorder during pregnancy.
Yale Study: Ketamine Disinhibits Dendrites and Enhances Calcium Signals in Prefrontal Dendritic Spines
In a study published in Nature Communications, Alex Kwan, PhD, Associate Professor of Psychiatry, and his research team found that within an hour after a mouse received ketamine, there is a substantial increase in the amount of calcium that goes into the dendritic spines for neurons in the prefrontal cortex.
Male Sexual Assault: Hidden Trauma
Why is male sexual assault largely overlooked and neglected by the public, survivors themselves, and some health care professionals? Joan Cook, PhD, Associate Professor of Psychiatry, spoke to Psychiatric Times in December after she gave a Grand Rounds lecture to the department and discussed the prevalence rate of sexual violence in boys and men.
Yale Review: How Brain Alterations Contribute to Suicidal Thoughts and Behaviors
How brain alterations contribute to suicidal thoughts and behaviors is the subject of a new published review of brain scanning studies by Yale and international researchers. Hilary Blumberg, MD, John and Hope Furth Professor of Psychiatric Neuroscience, and Professor of Psychiatry, in the Child Study Center and of Radiology and Biomedical Imaging at Yale, is the paper's lead and corresponding author.
Lin, Chang Place 5th in International Natural Language Processing Competition
Eric Lin, MD, a fourth-year resident in the Yale Department of Psychiatry, and David Chang, a student in Yale's Computation Biology & Bioinformatics program, placed fifth in the National NLP Clinical Challenges (n2c2) Clinical Semantic Textual Similarity (STS) Task.
Liu Emphasizes Collaboration in His Sports Neuroscience Research
Sports neuroscientist Kun Liu, PhD, Visiting Associate Professor of Psychiatry, spoke to the Chinese news service Ecns.cn about his program Physical Exercise Affecting on Cognition and Emotion (PEACE). The program incorporates the interdisciplinary field of sports science, neuroscience, and analytical chemistry in studying how and why physical activities can have a unique effect on certain cognitions.
Yale Researchers Measure Ketamine's Effects on a Glutamate Receptor
Sophie Holmes, PhD, Associate Research Scientist in Psychiatry, and Irina Esterlis, PhD, Associate Professor of Psychiatry, are the first and senior authors, respectively, of a study published in Journal of Cerebral Blood Flow & Metabolism that measured the effects of the anesthetic ketamine on a glutamate receptor.
Yale Imaging and Psychopharmacology Lab Publishes Articles in Molecular Psychiatry, Biological Psychiatry CNNI
Yale School of Medicine's Yale Imaging and Psychopharmacology Lab, directed by neuroscientist Sarah Yip, PhD, Assistant Professor of Psychiatry, has published research articles in Molecular Psychiatry and Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Yale Study: Connecticut Overdose Deaths Have More Than Doubled Since 2012
Greg Rhee, PhD, MSW, Adjunct Assistant Professor of Psychiatry, and Robert Rosenheck, MD, Professor of Psychiatry and of Health Policy, are co-authors of a paper published in Drug and Alcohol Dependence that found the rate of drug overdose deaths in Connecticut has more than doubled since 2012.